Related Experiment Video

Updated: Aug 18, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 20, 2013

Pulmonary fine structural changes in children with tissue hypoxia

M W Harrison, R S Connell, J R Campbell

    Journal of Pediatric Surgery
    |October 1, 1976
    PubMed

    Insights

    Four children showed lung ultrastructural changes linked to increased diffusion-perfusion of oxygen (DAVO2). These changes likely stem from microthrombi or microaggregates traveling to the lungs from under-oxygenated tissues.

    Area of Science:

    • Pulmonary Medicine
    • Pediatric Pathology
    • Cardiopulmonary Physiology

    Background:

    • Pediatric lung diseases require detailed structural analysis.
    • Understanding the link between oxygenation and lung pathology is crucial.

    Purpose of the Study:

    • To investigate the ultrastructural changes in lung biopsies of children.
    • To correlate these changes with preoperative oxygenation levels.

    Main Methods:

    • Lung biopsy was performed on six children.
    • Histopathological and ultrastructural examination of lung tissue.
    • Preoperative arterial blood gas analysis to determine diffusion-perfusion of oxygen (DAVO2).

    Main Results:

    • Four out of six children exhibited increased DAVO2.
    • These four children also showed significant ultrastructural abnormalities in their lung tissue.
    • No significant changes were noted in the other two children.

    Conclusions:

    • Increased DAVO2 in children may indicate underlying lung pathology.
    • Lung ultrastructural changes appear to be associated with microthrombi or microaggregates.
    • Embolization from under-oxygenated tissues is a potential cause of these pulmonary changes.

    More Related Videos

    Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices13:32

    Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices

    Published on: January 14, 2014

    Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

    Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

    Published on: May 11, 2015

    Related Concept Videos

    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

    Chronic Obstructive Pulmonary Disease-II: Pathophysiology

    Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
    Chronic Inflammation
    Atelectasis II: Pathophysiology01:10

    Atelectasis II: Pathophysiology

    Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
    Chronic Obstructive Pulmonary Disease II: Emphysema01:23

    Chronic Obstructive Pulmonary Disease II: Emphysema

    Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

    Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
    Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

    Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

    Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...